SUBSCRIBE
SUBSCRIBE
News   Business

ZIOPHARM Oncology, Inc. Needs More Cash to Develop Cancer Drugs

March 28, 2007 | 
1 min read

ZURICH, March 28 (Reuters) - U.S. biotechnology company Ziopharm Oncology Inc. (ZIOP.O: Quote, Profile , Research) will need more cash as it continues research into cancer drugs, its CEO told Reuters.

>>> Discuss This Story

Earnings Europe
MORE ON THIS TOPIC
Correct decision chosing - confused man character standing on the crossroads and looking at signpost with three different directions - conceptual vector illustration
Depression
Relmada Considering ‘Strategic Alternatives’ After Failure of Depression Asset
December 9, 2024
 · 
1 min read
 · 
Heather McKenzie
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Eli Lilly's biotechnology center in California
Manufacturing
Lilly Pumps $3B Into Wisconsin Site as Compounders Close In on Tirzepatide
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Manufacturing
Amgen to Add 370 New Jobs in North Carolina With $1B Manufacturing Investment
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac